Cost utility of the latest antipsychotics in severe schizophrenia (CUtLASS): a multi-centre, randomised, controlled trial

Not Applicable

Completed

• Conditions: Mental and behavioural disorders: Schizophrenia and other psychoses; Mental and Behavioural Disorders; Schizophrenia

• Registration Number: ISRCTN33419176
• Lead Sponsor: Department of Health (UK)

Brief Summary

2006 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16707074 HTA monograph

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2003-04-25
• Study Completion: 2003-06-30
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 227

Inclusion Criteria

Schizophrenics who are intolerant or resistant to usual treatment

Exclusion Criteria

1. Substance use or organic illness as the main cause of psychotic symptoms.
2. History of neuroleptic malignant syndrome (NMS)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration.